CCL2 and Alzheimer disease: We next checked whether SMYD3 knockdown had a direct effect on the inflammatory potential of differentiating AD-hMSCs, but no effect was observed on inflammatory markers such as IL1B, CCL2 and IL6 (Supplementary Fig. 5).